Science 37

Science 37 enables universal access to clinical research for patients and providers by providing decentralized clinical trials through our platform and unified technology.


New FDA Draft Guidance Shows That the Time for Decentralized Clinical Trials is Now.

July 05, 2023

On May 1, 2023, the U.S. Food and Drug Administration (FDA) released an updated Draft Guidance on decentralized trials. This release shows that the landscape of clinical research is rapidly evolving. The shift towards decentralized clinical trials presents an exciting opportunity for sponsors to improve patient engagement, enhance data quality, and accelerate clinical research. Are you prepared for what’s to come? Download the insight brief to learn more.

How to Meet the FDA’s Diversity Guidance

April 03, 2023

The pending FDA Guidelines is clear—pharma companies must improve diverse representation in clinical trials. In this whitepaper, Science 37 shares tips and strategies on how to achieve diversity in clinical trials.

How to Operationalize Oncology Trials with a Decentralized Approach

November 11, 2022

Download the Executive Oncology Clinical Trial Playbook to discover the premier, patient-centric strategy for solving hallmark challenges in oncology trials.